1 week Ago By ABMN Staff
StockNews.com upgraded shares of OraSure Technologies ( NASDAQ:OSUR – Free Report ) from a hold rating to a buy rating in a report released on Wednesday. OraSure Technologies Price Performance OSUR stock opened at $3.
61 on Wednesday. The firm has a 50 day simple moving average of $3.93 and a two-hundred day simple moving average of $4.
14. The stock has a market cap of $269.28 million, a PE ratio of 24.
07 and a beta of 0.03. OraSure Technologies has a one year low of $3.
52 and a one year high of $8.45. OraSure Technologies ( NASDAQ:OSUR – Get Free Report ) last released its earnings results on Wednesday, November 6th.
The medical instruments supplier reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.
02. OraSure Technologies had a return on equity of 3.55% and a net margin of 5.
07%. The business had revenue of $39.92 million for the quarter, compared to analysts’ expectations of $38.
97 million. During the same quarter in the prior year, the firm earned $0.27 earnings per share.
The firm’s revenue was down 55.2% on a year-over-year basis. On average, research analysts expect that OraSure Technologies will post -0.
08 EPS for the current fiscal year. Institutional Trading of OraSure Technologies OraSure Technologies Company Profile ( Get Free Report ) OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.
E.D. Further Reading Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.
com's FREE daily email newsletter ..
